Eva Lin

This study uses computational modeling and preclinical data to identify optimal dosing strategies for panRAF and MEK inhibitors in melanoma, revealing distinct dose requirements based on NRAS vs BRAF mutations.

PharmacoDB 2.0 enhances pharmacogenomics analysis by integrating new datasets, implementing FAIR pipelines, and improving drug response analysis tools.

The paper introduces a cloud-based platform called ORCESTRA for reproducible processing and sharing of multimodal biomedical data in a FAIR manner.